Investigating Different Mechanisms of Action in Combination Therapy for Influenza.
Investigating Different Mechanisms of Action in Combination Therapy for Influenza.
复制标题
DOI:
10.3389/fphar.2018.01207
复制
发表时间:
2018
影响因子:
5.6
通讯作者:
Dobrovolny HM
中科院分区:
文献类型:
--
作者:
Melville K;Rodriguez T;Dobrovolny HM
Combination therapy for influenza can have several benefits, from reducing the emergence of drug resistant virus strains to decreasing the cost of antivirals. However, there are currently only two classes of antivirals approved for use against influenza, limiting the possible combinations that can be considered for treatment. However, new antivirals are being developed that target different parts of the viral replication cycle, and their potential for use in combination therapy should be considered. The role of antiviral mechanism of action in the effectiveness of combination therapy has not yet been systematically investigated to determine whether certain antiviral mechanisms of action pair well in combination. Here, we use a mathematical model of influenza to model combination treatment with antivirals having different mechanisms of action to measure peak viral load, infection duration, and synergy of different drug combinations. We find that antivirals that lower the infection rate and antivirals that increase the duration of the eclipse phase perform poorly in combination with other antivirals.
登录
查看更多内容
影响因子:
3.7
作者:
Dobrovolny HM;Reddy MB;Kamal MA;Rayner CR;Beauchemin CA
通讯作者:
Beauchemin CA
影响因子:
4.6
作者:
Beauchemin CA;Miura T;Iwami S
通讯作者:
Iwami S
DOI:
10.3390/v7102875
发表时间:
2015-10-12
期刊:
Viruses
影响因子:
--
作者:
Boianelli A;Nguyen VK;Ebensen T;Schulze K;Wilk E;Sharma N;Stegemann-Koniszewski S;Bruder D;Toapanta FR;Guzmán CA;Meyer-Hermann M;Hernandez-Vargas EA
通讯作者:
Hernandez-Vargas EA
影响因子:
7.6
作者:
Bantia, Shanta;Kellogg, Debra;Babu, Y. S.
通讯作者:
Babu, Y. S.
影响因子:
2
作者:
Dobrovolny, Hana M.;Gieschke, Ronald;Beauchemin, Catherine A. A.
通讯作者:
Beauchemin, Catherine A. A.